Using adeno-associated virus as a tool to study retinal barriers in disease

Journal of Visualized Experiments

Volumn 2015, Issue 98, 2015, Pages

  Vacca, Ophélie ^a,b   El Mathari, Brahim ^a,b   Darche, Marie ^a,b   Sahel, José Alain ^a,b   Rendon, Alvaro ^a,b   Dalkara, Deniz ^a,b  

^a INSTITUT DE LA VISION   (France)

^b INSERM   (France)

Author keywords

Adeno Associated virus (AAV); Blood Retinal barrier (BRB); Inner limiting membrane (ILM); Issue 98; Medicine

Indexed keywords

ANIMAL; BLOOD RETINA BARRIER; C57BL MOUSE; CAPILLARY PERMEABILITY; CHEMISTRY; DEPENDOPARVOVIRUS; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; MACROGLIA; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; PHYSIOLOGY; REPORTER GENE; RETINA DISEASE; VIROLOGY;

ANIMALS; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; DEPENDOVIRUS; EPENDYMOGLIAL CELLS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; PERICYTES; RETINAL DISEASES; TRANSFECTION;

EID: 84941254161     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52451     Document Type: Article

References (24)

1. Halfter, W. Disruption of the retinal basal lamina during early embryonic development leads to a retraction of vitreal end feet, an increased number of ganglion cells, and aberrant axonal outgrowth. J Comp Neurol. 397 (1), 89-104, doi: 10.1002/(SICI)1096-9861(19980720)397:1<89::AID-CNE7>3.0.CO;2-E (1998).
2. Halfter, W., Dong, S., Balasubramani, M., & Bier, M. E. Temporary disruption of the retinal basal lamina and its effect on retinal histogenesis. Dev Biol. 238 (1), 79-96, doi:10.1006/dbio.2001.0396 (2001).
3. Halfter, W., Willem, M., & Mayer, U. Basement membrane-dependent survival of retinal ganglion cells. Invest Ophthalmol Vis Sci. 46 (3), 1000-1009, doi:10.1167/iovs.04-1185 (2005).
4. Abdelkader, E., & Lois, N. Internal limiting membrane peeling in vitreo-retinal surgery. Surv Ophthalmol. 53 (4), 368-396, doi:10.1016/j.survophthal.2008.04.006 (2008).
5. Dalkara, D. et al. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 17 (12), 2096-2102, doi:10.1038/mt.2009.181 (2009).
6. Bringmann, A. et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 25 (4), 397-424, doi:10.1016/j.preteyeres.2006.05.003 (2006).
7. Eichler, W., Kuhrt, H., Hoffmann, S., Wiedemann, P., & Reichenbach, A. VEGF release by retinal glia depends on both oxygen and glucose supply. Neuroreport. 11 (16), 3533-3537 (2000).
8. Kaur, C., Foulds, W. S., & Ling, E. A. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 27 (6), 622-647, doi:10.1016/j.preteyeres.2008.09.003 (2008).
9. Kaur, C., Sivakumar, V., & Foulds, W. S. Early response of neurons and glial cells to hypoxia in the retina. Invest Ophthalmol Vis Sci. 47 (3), 1126-1141, doi:10.1167/iovs.05-0518 (2006).
10. Xu, Q., Qaum, T., & Adamis, A. P. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci. 42 (3), 789-794 (2001).
11. Amato, R., Wesolowski, E., & Smith, L. E. Microscopic visualization of the retina by angiography with high-molecular-weight fluoresceinlabeled dextrans in the mouse. Microvasc Res. 46 (2), 135-142, doi:10.1006/mvre.1993.1042 (1993).
12. Yang, G. S. et al. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol. 76 (15), 7651-7660, doi: 10.1128/JVI.76.15.7651-7660.2002 (2002).
13. Li, W. et al. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye. Mol Vis. 15 267-275 (2009).
14. Koerber, J. T. et al. Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Mol Ther. 17 (12), 2088-2095, doi:10.1038/mt.2009.184 (2009).
15. Klimczak, R. R., Koerber, J. T., Dalkara, D., Flannery, J. G., & Schaffer, D. V. A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Muller cells. PLoS One. 4 (10), e7467, doi:10.1371/journal.pone.0007467 (2009).
16. Vacca, O. et al. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers. Glia. doi:10.1002/glia.22617 (2013).
17. Choi, V. W., Asokan, A., Haberman, R. A., & Samulski, R. J. Production of recombinant adeno-associated viral vectors. Curr Protoc Hum Genet. Chapter 12 Unit 12 19, doi:10.1002/0471142905.hg1209s53 (2007).
18. Choi, V. W., Asokan, A., Haberman, R. A., & Samulski, R. J.: Production of recombinant adeno-associated viral vectors for in vitro and in vivo use. Curr Protoc Mol Biol. Chapter 16 Unit 16 25, doi:10.1002/0471142727.mb1625s78 (2007).
19. McClure, C., Cole, K. L., Wulff, P., Klugmann, M., & Murray, A. J. Production and titering of recombinant adeno-associated viral vectors. J Vis Exp. (57), e3348, doi:10.3791/3348 (2011).
20. Aurnhammer, C. et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum Gene Ther Methods. 23 (1), 18-28, doi:10.1089/hgtb.2011.034 (2012).
21. Chiu, K., Chang, R. C., & So, K. F. Intravitreous injection for establishing ocular diseases model. J Vis Exp. (8), 313, doi:10.3791/313 (2007).
22. Kolstad, K. D. et al. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration. Hum Gene Ther. 21 (5), 571-578, doi:10.1089/hum.2009.194 (2010).
23. Sene, A. et al. Functional implication of Dp71 in osmoregulation and vascular permeability of the retina. PLoS One. 4 (10), e7329, doi:10.1371/journal.pone.0007329 (2009).
24. Benard, R. A New Quantifiable Blood Retinal Barrier Breakdown Model In Mice. ARVO Annual Meeting, poster presentation #4518/A272 (2011).